spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Kirsten de Bruijn joins Qatar Airways Cargo

Qatar Airways Group

Qatar Airways Cargo is delighted to announce that Kirsten de Bruijn has joined the Airline in the capacity of Senior Vice President, Cargo Sales and Network Planning




An Air Cargo veteran with 13 years of experience in management in the air cargo industry, she shares Qatar Airways belief that the pace of change brought about by recent global events demands value centred leadership around revenue and margin management: “The COVID-19 crisis has accelerated the need for flexibility and agility. It has also fast-tracked demand for digitalization. Optimizing the utilization of freighters, the network, pricing and processes will mean embracing digital as the central vector of change. Qatar Airways is a world leader in this space and our ability to constantly adapt and adjust will continue to be part of the fundamental premise of our air cargo strategy,” said Guillaume Halleux, Chief Officer Cargo at Qatar Airways.

According to Guillaume Halleux, Kirsten was the obvious choice: “We share the same vision of the industry and Kirsten perfectly understands the sector’s demands – as well as its volatility and its extremely competitive nature. She is able to challenge existing processes thanks to her customer-focused vision and extremely high standards. She is a major asset to the Airline.”

According to Kirsten, “Air cargo is probably one of the most competitive industries out there. It means you have to find ways to avoid being commoditized and you have to think globally – to constantly be aware of the speed with which technology is changing how we do business. Qatar Airways Cargo represents the cutting edge of change in the global air cargo market. I want to be a part of that movement. Part of my role is to build a sense of team spirit and collective purpose. I like to hire people that are better at what they do than I am, so I can create the best team possible.”

With Kirsten on board, Qatar Airways Cargo is well positioned to capitalize on its ambitious growth strategy as it strives to expand its leadership in the global airfreight market.
phone +974 40222072
email qrmedia@qatarairways.com.qa
web www.qatarairways.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harbouring Exon 20 Insertion Mutations

BEERSE, BELGIUM, May 18, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1 CHRYSALIS study evaluating amivantamab (JNJ-6372) in the treatment of patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion mutations.[i] Amivantamab is an EGFR and MET-targeted bispecific antibody, which targets activating and resistance EGFR mutations, and MET pathway activation.[ii],[iii] Investigators assessed efficacy using overall response rate (ORR) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1), duration of response, as well as the safety profile of amivantamab,1 which were the basis of the U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation granted earlier this year.[iv]
More info >>


White Papers

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

RSSL

The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement